Andreas Kalogeropoulos, MD, PhD

Assistant Professor of Medicine, Division of Cardiology

Emory University School of Medicine

Phone: 404-778-3652

Fax: 404-727-6495

Email: akaloge@emory.edu

Additional Contact Information

Mailing Address:

Emory Clinical Cardiovascular Research Institute (ECCRI)

1462 Clifton Road
Suite 535B

Atlanta, GA 30322

Biography

Andreas Kalogeropoulos, MD, MPH, PhD, is a clinical and outcomes researcher in the fields of heart failure and echocardiography. After completing his clinical training at the University of Patras, Greece, he pursued additional training in clinical and outcomes research at Emory University (Atlanta, GA). Dr. Kalogeropoulos has joined the faculty of the Division of Cardiology at Emory University as Assistant Professor in 2010. He has has authored or co-authored over 110 original research, review, and editorial articles in peer-reviewed journals and two book chapters. Dr. Kalogeropoulos has received grants and awards from Emory University, the American Society of Echocardiography, and the American Heart Association for research projects related to myocardial deformation imaging, advanced heart failure, and congenital heart disease. He currently serves on the Editorial Boards of the Journal of the American Society of Echocardiography and the Journal of Cardiac Failure. Dr. Kalogeropoulos serves on the Research Awards Committee of the American Society of Echocardiography, the National Cardiovascular Data Registry Research & Publications Subcommittee, as well as on other institutional and international scientific committees. His research currently focuses on (1) risk factors, outcomes, and predictive models for patients with heart failure and (2) applications of modern echocardiography for patients with heart failure and congenital heart disease. 

Research

Dr. Kalogeropoulos’ research focuses on (1) clinical applications of standard and newer echocardiographic and techniques for the evaluation of patients with heart failure and congenital heart disease; (2) risk factors, biomarkers, outcomes, and predictive models for patients with heart failure; and (3) risk stratification for heart failure in the general population.

Publications